Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Noctrix Health Completes $40M Series C Round

PLEASANTON, CA, Noctrix Health announced today that it has closed a $40 million Series C financing round.
The round was led by Sectoral Asset Management with participation from other new investors Angelini Ventures, ResMed, and Asahi Kasei Corporation with strong support from insiders including OrbiMed and Treo Ventures. This infusion of capital will propel the advancement of Nidra™ Tonic Motor Activation (TOMAC) therapy towards its eagerly anticipated launch in the US market. Nidra™, a revolutionary new device, stands as the first and only approved treatment for drug-refractory Restless Legs Syndrome (RLS), a chronic condition that has debilitating impacts on sleep and quality of life of millions of adults worldwide.

Noctrix Health is a medical device company committed to developing clinically validated breakthrough medical technologies that improve the quality of life for patients with chronic conditions.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors